Linked Life Data

20695883

Source:http://linkedlifedata.com/resource/pubmed/id/20695883

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2010-11-22
pubmed:abstractText
Peritoneal fibrosis manifests clinically as membrane failure or encapsulating peritoneal sclerosis (EPS). There are no clinical or biochemical tests to determine the rate of progression of peritoneal fibrosis. CCL18/pulmonary and activation-regulated chemokine (PARC) is profibrotic and stimulates collagen production independent of the effect of transforming growth factor beta. This has not been studied in peritoneal dialysis (PD) patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1365-2362
pubmed:author
pubmed:copyrightInfo
© 2010 The Authors. European Journal of Clinical Investigation © 2010 Stichting European Society for Clinical Investigation Journal Foundation.
pubmed:issnType
Electronic
pubmed:volume
40
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1067-73
pubmed:meshHeading
pubmed:year
2010
pubmed:articleTitle
CCL18 in peritoneal dialysis patients and encapsulating peritoneal sclerosis.
pubmed:affiliation
Imperial College Kidney and Transplant Institute, Hammersmith Hospital, London, UK. sohailahmad@doctors.org.uk
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't